Efficacy and Safety of Robotic-assisted Bronchoscopy Combined With the ICNVA Strategy in Biopsy of Peripheral Pulmonary Nodules

Inclusion criteria

• Age ≥18 years old, and ≤75 years old, male or female;
• Patients with peripheral lung lesions found by chest CT, whose diameter ≥ 6mm and < 3cm, who plan to undergo robotic-assisted bronchoscopic for pulmonary biopsy;
• The patient voluntarily undergo bronchoscopy and meet the requirements for bronchoscopy;
• Patients can understand the purpose of the trial, have good compliance with the examination and follow-up, voluntarily participate in the clinical trial and sign the informed consent.

Exclusion criteria

• Patients with cardiovascular diseases, such as blood pressure instability, myocardial infarction or arrhythmia;
• Patients with massive hemoptysis within two weeks;
• Patients with severe pneumothorax and rib fracture;
• Patients with serious infectious diseases, such as tuberculosis or AIDS;
• Patients with severe abdominal aortic aneurysm or thoracic aortic aneurysm;
• Participants who have participated in or are participating in drug clinical trials within 3 months before screening, or have participated in other medical device clinical trials within 30 days;
• Those who were not considered suitable for inclusion by the researchers.